BioXcel Therapeutics (BTAI) Other financing activities (2019 - 2026)
BioXcel Therapeutics (BTAI) posted quarterly Other financing activities of $6.2 million for Q1 2026, up 166.49% quarter-over-quarter from $2.3 million in Q4 2024.
BioXcel Therapeutics (BTAI) Other financing activities (2019 - 2026) Analysis & Trends
BioXcel Therapeutics' Other financing activities history runs 7 years deep, the most recent figure standing at $6.2 million for Q1 2026.
- In Q1 2026, Other financing activities changed N/A year-over-year to $6.2 million; the TTM figure through Mar 2026 stood at $6.2 million (up 166.49% YoY), while the FY2024 annual figure was $2.5 million, up 400.0% from the prior year.
- Other financing activities for Q1 2026 stood at $6.2 million, up from $2.3 million in the prior quarter.
- The five-year high for Other financing activities was $6.2 million in Q1 2026, with the low at $48000.0 in Q3 2022.
- The 4-year median for Other financing activities is $1.3 million (2023), against an average of $1.9 million.
- The sharpest annual moves came in 2022 and 2023: Other financing activities soared 552.92% in 2022, then tumbled 92.3% in 2023.
- BioXcel Therapeutics' Other financing activities stood at $3.0 million in 2022, then plunged by 91.7% to $250000.0 in 2023, then jumped by 826.4% to $2.3 million in 2024, then soared by 166.49% to $6.2 million in 2026.
- Business Quant data shows BTAI's Other financing activities at $6.2 million in Q1 2026, $2.3 million in Q4 2024, and $224000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - |
| 10 | BioXcel Therapeutics | 24.46 Mn | 24.46 Mn | 160,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.42 Mn |
| Jun 30, 2026 | 1.42 Mn |
| Mar 31, 2026 | 6.17 Mn |
| Mar 31, 2026 | 6.17 Mn |
| Dec 31, 2024 | 2.32 Mn |
| Dec 31, 2024 | 2.32 Mn |
| Mar 31, 2024 | 224,000.00 |
| Mar 31, 2024 | 224,000.00 |
| Jun 30, 2023 | 250,000.00 |
| Jun 30, 2023 | 250,000.00 |
| Mar 31, 2023 | 258,000.00 |
| Mar 31, 2023 | 258,000.00 |
| Dec 31, 2022 | 3.01 Mn |
| Dec 31, 2022 | 3.01 Mn |
| Sep 30, 2022 | 48,000.00 |
| Sep 30, 2022 | 48,000.00 |
| Jun 30, 2022 | 3.25 Mn |
| Jun 30, 2022 | 3.25 Mn |
| Sep 30, 2021 | 105,000.00 |
| Sep 30, 2021 | 105,000.00 |